Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence for Medication Management in Discordant Chronic Comorbidities: An Analysis from Healthcare Provider and Patient Perspectives
1
Zitationen
3
Autoren
2025
Jahr
Abstract
Recent advances in artificial intelligence (AI) have created opportunities to enhance medical decision-making for patients with discordant chronic conditions (DCCs), where a patient has multiple, often unrelated, chronic conditions with conflicting treatment plans. This paper explores the perspectives of healthcare providers (n = 10) and patients (n = 6) regarding AI tools for medication management. Participants were recruited through two healthcare centers, with interviews conducted via Zoom. The semi-structured interviews (60–90 min) explored their views on AI, including its potential role and limitations in medication decision making and management of DCCs. Data were analyzed using a mixed-methods approach, including semantic analysis and grounded theory, yielding an inter-rater reliability of 0.9. Three themes emerged: empathy in AI–patient interactions, support for AI-assisted administrative tasks, and challenges in using AI for complex chronic diseases. Our findings suggest that while AI can support decision-making, its effectiveness depends on complementing human judgment, particularly in empathetic communication. The paper also highlights the importance of clear AI-generated information and the need for future research on embedding empathy and ethical standards in AI systems.
Ähnliche Arbeiten
Prediction of Creatinine Clearance from Serum Creatinine
1976 · 15.338 Zit.
A method for estimating the probability of adverse drug reactions
1981 · 11.454 Zit.
ECDEU Assessment Manual for Psychopharmacology
1976 · 8.823 Zit.
Adherence to Medication
2005 · 7.870 Zit.
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 · 4.798 Zit.